Patents by Inventor Joseph G Vockley

Joseph G Vockley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene expression profiles in esophageal tissue
    Publication number: 20040033502
    Abstract: The invention concerns a novel nucleic acid fragment of the genome of rice pathogenic fungus Magnaporthe grisea comprising a gene coding for a protein (hereafter referred to as gene 763) whereof the presence and integrity are indispensable for pathogenesis of said fungus with respect to rice and barley. The invention also concerns the promoter of said gene, the gene coding for protein 763, protein 763 and uses thereof for identifying potential biological targets for novel fungicide molecules and for isolating genes coding for proteins controlling biochemical functions essential to the pathogenesis of the fungus Magnaporthe grisea with respect to rice and barley. The invention further concerns compounds inhibiting pathogenesis of fungi related to the expression of gene 763.
    Type: Application
    Filed: June 12, 2003
    Publication date: February 19, 2004
    Inventors: Amanda Williams, Joseph F. Boland, Reginald V. Lord, Christopher Alvares, Jon C. Wetzel, Uwe Scherf, Joseph G. Vockley
  • Arginase II
    Publication number: 20020119554
    Abstract: The invention relates to Arginase II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Application
    Filed: September 14, 2001
    Publication date: August 29, 2002
    Inventors: Joseph G. Vockley, Patrick J. Dillon
  • Arginase II
    Patent number: 6316199
    Abstract: The invention relates to Arginase II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: November 13, 2001
    Assignee: diaDexus, Inc.
    Inventors: Joseph G Vockley, Patrick J Dillon
  • Arginase II
    Patent number: 6054308
    Abstract: The invention relates to Arginase II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Grant
    Filed: July 15, 1998
    Date of Patent: April 25, 2000
    Assignees: SmithKline Beecham Corporation, Human Genome Sciences, Inc.
    Inventors: Joseph G Vockley, Patrick J Dillon
  • Arginase II
    Patent number: 5912159
    Abstract: The invention relates to Arginase II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Grant
    Filed: August 20, 1997
    Date of Patent: June 15, 1999
    Assignees: Smithkline Beecham Corp., Human Genome Sciences, Inc.
    Inventors: Joseph G Vockley, Patrick J Dillon
  • Arginase II
    Patent number: 5780286
    Abstract: The invention relates to Arginase II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Grant
    Filed: August 20, 1996
    Date of Patent: July 14, 1998
    Assignees: SmithKline Beecham Corporation, Human Genome Sciences Inc.
    Inventors: Patrick J. Dillon, Joseph G. Vockley